Hiroyuki Kanno

2.5k total citations
91 papers, 1.8k citations indexed

About

Hiroyuki Kanno is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Hiroyuki Kanno has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 32 papers in Oncology and 25 papers in Immunology. Recurrent topics in Hiroyuki Kanno's work include Lymphoma Diagnosis and Treatment (28 papers), Viral-associated cancers and disorders (20 papers) and Immune Cell Function and Interaction (13 papers). Hiroyuki Kanno is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Viral-associated cancers and disorders (20 papers) and Immune Cell Function and Interaction (13 papers). Hiroyuki Kanno collaborates with scholars based in Japan, United States and Chile. Hiroyuki Kanno's co-authors include Masahiko Ohsawa, Katsuyuki Aozasa, Norifumi Naka, Atsumasa Uchida, Yasuhiko Tomita, Y. Tomita, Katsuyuki Aozasa, Takashi Sawai, Akira Myoui and Masahiro Yasunaga and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer.

In The Last Decade

Hiroyuki Kanno

84 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Kanno Japan 25 941 465 418 367 350 91 1.8k
Tilmann Spieker Germany 25 913 1.0× 346 0.7× 665 1.6× 342 0.9× 928 2.7× 61 2.8k
Emily Z. Keung United States 23 1.1k 1.1× 868 1.9× 164 0.4× 259 0.7× 296 0.8× 73 1.8k
Heinz Sill Austria 32 912 1.0× 344 0.7× 438 1.0× 176 0.5× 1.2k 3.4× 137 3.3k
Ilse Schwarzinger Austria 36 840 0.9× 303 0.7× 437 1.0× 245 0.7× 1.2k 3.4× 136 4.0k
Helen Feiner United States 32 621 0.7× 551 1.2× 417 1.0× 549 1.5× 825 2.4× 80 3.0k
Semra Paydaş Türkiye 28 1.0k 1.1× 391 0.8× 633 1.5× 87 0.2× 627 1.8× 208 2.7k
Javier Gómez‐Román Spain 27 937 1.0× 1.1k 2.3× 357 0.9× 306 0.8× 899 2.6× 140 2.9k
Alan D. Glick United States 29 646 0.7× 496 1.1× 828 2.0× 282 0.8× 442 1.3× 83 2.9k
John M. McCarty United States 23 983 1.0× 623 1.3× 238 0.6× 175 0.5× 590 1.7× 70 3.6k
Rüdiger P. Laubender Germany 29 803 0.9× 330 0.7× 178 0.4× 228 0.6× 355 1.0× 60 2.3k

Countries citing papers authored by Hiroyuki Kanno

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Kanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Kanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Kanno more than expected).

Fields of papers citing papers by Hiroyuki Kanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Kanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Kanno. The network helps show where Hiroyuki Kanno may publish in the future.

Co-authorship network of co-authors of Hiroyuki Kanno

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Kanno. A scholar is included among the top collaborators of Hiroyuki Kanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Kanno. Hiroyuki Kanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kanno, Hiroyuki, et al.. (2023). Establishment of Epstein–Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1. Microorganisms. 11(11). 2624–2624. 2 indexed citations
3.
Katano, Harutaka, et al.. (2022). An autopsy case of fulminant myocarditis after severe acute respiratory syndrome coronavirus 2 vaccine inoculation. Pathology International. 72(10). 519–524. 5 indexed citations
4.
Tateishi, Ayako, et al.. (2020). The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis. Immunologic Research. 68(3). 152–160. 3 indexed citations
5.
6.
Tateishi, Ayako, Satoshi Ohira, Yoichiro Yamamoto, & Hiroyuki Kanno. (2018). Histopathological findings of pregnancy-induced hypertension: histopathology of early-onset type reflects two-stage disorder theory. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(4). 635–642. 16 indexed citations
7.
Nakamura, Yutaka, Ryo Suzuki, Koichi Abe, et al.. (2016). Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma. Clinical & Experimental Allergy. 46(9). 1152–1161. 12 indexed citations
8.
Sawai, Takashi, Yasuhiro F. Miura, Akihisa Kamataki, et al.. (2013). World’s first telepathology experiments employing ultra-high-speed internet satellite, nicknamed “KIZUNA”. Journal of Pathology Informatics. 4(1). 24–24. 3 indexed citations
9.
Noda, Yutaka, Naotaka Fujita, Go Kobayashi, et al.. (2011). PROSPECTIVE RANDOMIZED CONTROLLED STUDY COMPARING CELL BLOCK METHOD AND CONVENTIONAL SMEAR METHOD FOR PANCREATIC JUICE CYTOLOGY. Digestive Endoscopy. 24(3). 168–174. 10 indexed citations
10.
Kawasaki, Yukihiko, Kei Takano, Masato Isome, et al.. (2007). Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephrotic syndrome. Journal of Nephrology. 20(1). 52–56. 12 indexed citations
11.
Yazaki, Masahide, et al.. (2006). Progressive Wild-Type Transthyretin Deposition after Liver Transplantation Preferentially Occurs onto Myocardium in FAP Patients. American Journal of Transplantation. 7(1). 235–242. 93 indexed citations
12.
Kurose, Akira, et al.. (2005). Lymphoepithelioma-like carcinoma of the breast. Report of a case with the first electron microscopic study and review of the literature. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 447(3). 653–659. 23 indexed citations
13.
Yoshimura, Fayth K., Hiroyuki Kanno, Miwa Uzuki, et al.. (2005). Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D. Osteoarthritis and Cartilage. 14(5). 435–441. 15 indexed citations
14.
Shintani, Yasushi, et al.. (1999). A CASE OF CANCER OF THE PAPILLA VATER CAUSING DUODENAL INTUSSUSCEPTION AFTER GASTRECTOMY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 60(9). 2395–2399.
15.
Ohsawa, Masahiko, Shin‐ichi Nakatsuka, Hiroyuki Kanno, et al.. (1999). Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. International Journal of Cancer. 81(6). 865–870. 43 indexed citations
16.
Aozasa, Katsuyuki, Masahiko Ohsawa, Y. Tomita, & Hiroyuki Kanno. (1998). EPSTEIN-BARR VIRUS AND MALIGNANT LYMPHOMA. 45. 117–127. 1 indexed citations
17.
Nakagawa, Kouichi, Hiroyuki Kanno, & Yutaka Miura. (1997). Detection and Analyses of Ascorbyl Radical in Cerebrospinal Fluid and Serum of Acute Lymphoblastic Leukemia. Analytical Biochemistry. 254(1). 31–35. 26 indexed citations
18.
Naka, Norifumi, Masahiko Ohsawa, Yasuhiko Tomita, et al.. (1996). Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases. Journal of Surgical Oncology. 61(3). 170–176. 158 indexed citations
19.
Shuin, Taro, Keiichi Kondo, Norio Sakai, et al.. (1995). [Results of mutation analyses of von Hippel-Lindau disease gene in Japanese patients: comparison with results in United States and United Kingdom].. PubMed. 41(9). 703–7. 7 indexed citations
20.
Kanno, Hiroyuki, et al.. (1994). Immune complex-degradation ability of macrophages in MKL/Mp-lpr/lprlupus mice and its regulation by cytokines. Clinical & Experimental Immunology. 95(1). 115–121. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026